Computational Analysis of an Evolutionarily Conserved VertebrateMuscle Alternative Splicing Program by Das, Debopriya et al.
Computational Analysis of an Evolutionarily Conserved Vertebrate 





Debopriya Das*, Tyson A. Clark*, Anthony Schweitzer, Henry Marr, Miki L. 
Yamamoto, Marilyn K. Parra, Josh Arribere, Simon Minovitsky, Inna Dubchak, John E. 
Blume, John G. Conboy 
 
* These authors contributed equally to this work 
running title: muscle alternative splicing in vertebrate genomes 





A novel exon microarray format that probes gene expression with single exon resolution was employed 
to elucidate critical features of a vertebrate muscle alternative splicing program. A dataset of 56 
microarray-defined, muscle-enriched exons and their flanking introns were examined computationally in 
order to investigate coordination of the muscle splicing program. Candidate intron regulatory motifs 
were required to meet several stringent criteria: significant over-representation near muscle-enriched 
exons, correlation with muscle expression, and phylogenetic conservation among genomes of several 
vertebrate orders. Three classes of regulatory motifs were identified in the proximal downstream intron, 
within 200nt of the target exons: UGCAUG, a specific binding site for Fox-1 related splicing factors; 
ACUAAC, a novel branchpoint-like element; and UG- / UGC-rich elements characteristic of binding sites 
for CELF splicing factors. UGCAUG was remarkably enriched, being present in nearly one-half of all 
cases. These studies suggest that Fox and CELF splicing factors play a major role in enforcing the 
muscle-specific alternative splicing program, facilitating expression of a set of unique isoforms of 
cytoskeletal proteins that are critical to muscle cell differentiation.  
 
Supplementary materials: There are four supplementary tables and one supplementary figure. The tables 
provide additional detailed information concerning the muscle-enriched datasets, and about over-
represented oligonucleotide sequences in the flanking introns. The supplementary figure shows RT-PCR 
data confirming the muscle-enriched expression of exons predicted from the microarray analysis. 
 
Introduction 
 Alternative pre-mRNA splicing is a critical mechanism for regulating gene expression in 
metazoan organisms, and is often cited as a mechanism for generating tremendous protein diversity from 
a relatively small number of genes. A majority of human genes exhibit some form of alternative 
splicing, and examples abound for which alternative protein isoforms encoded by a single gene exhibit 
differences in structure, function, or subcellular localization. Intriguingly, a small but critical proportion 
of these splicing events is subject to spatial and temporal regulation during differentiation and 
development.  Thus, the human genome encodes a complex alternative splicing program that switches 
alternative exons on and off according to the needs of individual differentiated cell types.  
 Despite intensive study in recent years, the mechanisms regulating the human alternative splicing 
program are not yet well understood. Biochemical and computational studies have revealed the existence 
of sequence-specific RNA binding proteins that interact with cis-acting regulatory elements in 
alternative exons, and their flanking intron sequences, to regulate the splicing efficiency of alternative 
exons. Detailed studies of model pre-mRNAs have established that splicing efficiency is modulated by 
the activities of stimulatory trans-acting factors binding at enhancer motifs in the RNA, and inhibitory 
factors acting at silencer elements. Several cases in which splicing decisions are determined by the 
relative concentrations of antagonistic positive and negative factors have been described (e.g., (1-9). 
 However, the full extent of tissue-specific alternative splicing patterns has not been appreciated 
on a genome-wide scale, limiting our ability to understand its contribution to cell- type specialization 
and to understand the rules that govern temporal and spatial patterns of alternative splicing. Biochemical 
splicing assays, computational analyses of RNA sequences proximal to alternative exons, and CLIP 
(crosslink and immunoprecipitation) strategies have begun to reveal some of the important elements for 
tissue-specific splicing. Thus, NOVA1- and Fox1-related splicing factors are required for correct 
regulation of brain-specific splicing events (10-14), and muscle-specific exons can be regulated by 
proteins of the CELF family of splicing factors and by muscleblind proteins (3,15-19).   
 Recent advances in microarray technology now facilitates characterization of gene expression at 
the level of single exons, and thereby offers an important new tool for broad analysis of alternative 
splicing programs (11,20-29).  In this study, we employed a new Affymetrix exon microarray format to 
identify 56 muscle-enriched alternative exons, a number of which are predicted to alter the expression of 
cytoskeletal related genes.  Computational analysis of flanking introns revealed a remarkable 
concentration of binding sites for splicing factors of the Fox1, CELF, and PTB families adjacent to the 
muscle-enriched exons, a pattern that was conserved in the genomes of several vertebrate orders. 
Together these observations provide the most comprehensive picture yet available of a muscle-specific 
alternative splicing program and suggest that Fox and CELF-related proteins play a critical role in 




Identification and characterization of muscle-enriched alternative exons.  The prototypical 
human muscle-enriched exon dataset analyzed in this study (Table I) was derived from genome-wide 
exon microarray hybridization data. The final dataset consisted of 56 muscle-enriched, internal cassette 
exons that exhibited an elevated “splicing index” in muscle, i.e.,  a higher intensity of alternative exon 
expression, normalized to the parent transcript expression level, in heart and skeletal muscle than in 
nonmuscle samples. Most of these exons (~80%) are integral multiples of 3nt in length, with a median 
size of 84nt, consistent with the notion that alternative exons are smaller than average constitutive exons 
(145nt; ref. 30,31). To explore evolutionary conservation of candidate splicing regulatory elements, we 
also identified highly conserved orthologs for most of these human muscle-enriched exons in mouse, 
chicken, and frog (Supplementary Table I.)  
Muscle-enriched splicing patterns for a few of these exons were validated experimentally in the 
human dataset by RT/PCR (Figure 1). Although splicing patterns were not absolutely muscle-specific, in 
each case the efficiency of exon inclusion was highest in heart and skeletal muscle, thus confirming the 
predictions of the exon microarray. Importantly, mRNA and/or EST evidence from the genetic databases 
(not shown) demonstrates that the majority of these exons are alternatively spliced in at least one of the 
other species examined (mouse, chicken, or frog), suggesting that the incidence of conserved alternative 
exons in this specialized dataset is higher than the reported rate for general alternative exons (32). 
Together these results indicate that muscle-enriched exons whose alternative splicing exhibits 
programmed changes during differentiation constitute a special class of highly conserved alternative 
exons.  
 
Analysis of downstream intron sequences. Alternative splicing regulatory elements responsible for 
tissue-specific splicing are often located in flanking intron sequences. To search for candidate intronic 
regulatory motifs for the muscle-specific splicing program, we used a word counting program (13,14) to 
identify oligonucleotide sequences that are over-represented near muscle-enriched exons, and a 
hypergeometric analysis to examine motif distribution among the individual exons of each dataset.  The 
significance of candidate regulatory motifs was further investigated by correlation analysis of motif 
frequency with splicing index. Finally, we examined their spatial and phylogenetic conservation through 
vertebrate evolution (14).  Motifs meeting these combined criteria were judged to be very strong 
candidates for regulating muscle-specific alternative splicing events.  
Application of these computational strategies to the downstream intron region yielded the results 
presented in Table I (for the human muscle dataset) and Supplementary Table I (for the mouse, chicken 
and frog datasets). Table I shows the top 30 motifs in the downstream 200 nt (D200) of intron sequence, 
ranked in order by the frequency difference (frequency in muscle dataset minus frequency in control 
dataset). Most of these motifs were highly significant by the hypergeometric measures as well, 
supporting a potential role in regulation of muscle-specific alternative splicing (Table I). 
Correlation of motif frequency with expression data has been used effectively to decipher cis-
regulatory motif combinations that are functional in regulating gene transcription (33,34).  When a 
similar strategy was applied here to the list of candidate splicing regulatory motifs, nine motifs were 
found to be positively correlated with the muscle splicing index (correlation p-values < 0.05). These 
motifs fell into three distinct classes: (1) the Fox1 binding motif UGCAUG (p-value = 6.79x10-5) and five 
closely related hexamers (UUUGCA,  UUGCAU,  AUGCAU, GCAUGG, GUGCAU); (2)  UG-rich elements 
GUGUGU and UCUGUG (correlation p-values=0.032 and 0.015, respectively), that resemble binding sites 
for the CELF family of splicing factors; and (3) the novel motif ACUAAC (p-value=0.0006), which is 
similar to the UACUAAC element that was noted in a recent study of muscle-specific exons in mouse (28).  
Each of these classes is analyzed further in the following sections. 
 
Identification of the unique Fox1 splicing factor binding site, UGCAUG, as the strongest 
candidate regulatory element for muscle-specific alternative splicing. 
The most prominent motif by all measures is the Fox1 binding motif, UGCAUG. This hexamer 
was strongly over-represented in the first 200nt of proximal downstream intron sequence (D200), at a 
level greater than expected for any hexamer, It occurred at 6-10-fold higher frequency than expected by 
chance, or observed in the comparable D200 region of the control datasets. UGCAUG was also the most 
over-represented hexamer in the mouse, chicken, and frog datasets (Supplementary Table II), and 
exhibited  the strongest correlation with the muscle splicing index (Table I). 
The occurrence of UGCAUG motifs was widespread among muscle-enriched exons: in the D200 
region, ~40-50% of exons in the human (23/56), mouse (21/54), chicken (20/43), and frog (19/36) 
muscle-enriched datasets possessed at least one such motif. Phylogenetic and spatial conservation of 
UGCAUG elements was further examined by determining abundance as a function of position relative to 
the regulated alternative exon. Figure 2 shows that in all four species, UGCAUG motifs were specifically 
concentrated in the D200 region. In contrast, the frequency of UGCAUG elements was substantially 
reduced in more distal downstream introns, in the upstream introns, and in all regions of the control 
dataset. Nontissue-specific alternative exons also lack this concentration of UGCAUG motifs in D200 
(14). Interestingly, although UGCAUG motifs in the population of muscle enriched exons were distributed 
within the broader D200 region, in individual cases UGCAUG motif(s) associated with a particular 
orthologous exon tended to be highly conserved at specific sites within the D200 across different 
vertebrate genomes (analogous to (14), Figure 2).  
Together these results indicate a major role for Fox1-related splicing factor(s) in the regulation of 
the muscle alternative splicing program of vertebrates. However, since previous studies have reported 
GCAUG as the binding site for a Fox1-related zebrafish protein (35), we also examined the distribution of 
this pentamer in the muscle-enriched datasets. In all four species GCAUG was indeed highly over-
represented (data not shown); however, most GCAUG elements in the D200 regions occurred in the 
context of the full UGCAUG hexamer (human, 28/43= 65%; mouse, 23/40=58%; chicken, 23/31= 74%; 
frog, 25/33=76%).  A similar result was obtained upon analysis of the proximal downstream intron 
sequences for brain-enriched exons (14). This data suggests that UGCAUG is likely predominant 
functional regulatory element for muscle-enriched exons, but also allows for the possibility that GCAUG 
is functional in some cases.  
 
Characterization of the CELF splicing factor binding sites as candidate regulatory elements for 
muscle-specific alternative splicing.  CELF- and muscleblind-related splicing factors have been shown 
experimentally to play important roles in the alternative splicing of selected muscle-specific exons 
(3,15-19). We therefore examined our larger muscle-enriched alternative exon dataset for regulatory 
motifs that might suggest a wider role for CELF proteins in regulation of the muscle alternative splicing 
program. Such motifs have been reported to include UG-repeat sequences and CUG- or UGC-motifs 
(3,15). 
UGUGUG and GUGUGU were among a group of UG–rich motifs in the top 10 over-represented 
hexamer motifs of the human muscle dataset, as ranked by frequency difference (Table I and 
Supplementary Table II). As mentioned above, GUGUGU was also one of the few motifs that was 
strongly correlated with the muscle splicing index. These findings are in stark contrast to what is 
observed for brain-enriched alternative exons, where over-representation of UG–rich motifs is not 
pronounced (14).   
 Further analysis of UGUGUG was performed by phylogenetic and spatial analysis of its 
distribution among the introns flanking muscle-enriched exons.  Spatially, the highest frequency of 
UGUGUG motifs was localized in all four species to a narrow region, the first 50nt of downstream intron 
(D50), although there was a moderate background frequency in more distal intronic regions (Figure 3). 
The over-representation in the D50 region was statistically significant when judged by the overall 
frequency of motifs in the dataset (resampling confidence values <0.005 in human, mouse, and frog; < 
0.05 in chicken) or by the proportion of muscle-enriched exons possessing this downstream motif 
(hypergeometric P values ≤0.01 for all four species), in comparison to the species matched control 
datasets.  The latter measure suggests that the enrichment of UGUGUG was due to a general distribution 
of the motif among all muscle-enriched exons, rather than from repeated elements in one or a few D50 
sequences.  
Analysis of trinucleotides in proximal downstream intron sequences revealed that CUG was 
relatively abundant, but not over-represented relative to the control exon datasets. In contrast, UGC was 
highly over-represented in the most proximal downstream region of all four vertebrates tested, with a 
frequency difference ranking first in human, mouse, and frog (P< 0.0001 for all three species) and 
second in chicken (P<0.004).  
The novel motif ACUAAC is a candidate regulatory element for a subset of muscle enriched 
exons.  The identification of ACUAAC as an over-represented motif that correlates with the muscle 
splicing index in the human dataset prompted us to further investigate its potential role as a regulator of 
muscle-specific exons. As shown in Figure 4, ACUAAC was specifically and phylogenetically conserved 
in the proximal downstream intron region in all four species. Approximately ~ 20% of the exons in each 
dataset possessed ACUAAC in the D200 region, approximately 4-fold greater than expected by chance. 
The over-representation of ACUAAC relative to species-matched control exons was highly statistically 
significant for all four species (hypergeometic p-values:  human, 2.5x10-08; mouse, 2.8 x10-08; chicken, 6 
x10-04; and frog, 1.7 x10-07). Moreover, analysis of individual exons revealed high spatial conservation 
as well: the MTMR3 and RBM9 exons were among nine cases in which the intron locations of ACUAAC 
elements were conserved in the proximal downstream intron for at least three of the four species. This 
novel element may therefore be essential for proper regulation of a subset of muscle-enriched exons. 
This motif is similar to the UACUAAC motif recently reported to be over-represented downstream of a 
smaller dataset of muscle-enriched exons in the mouse (28). 
 
Analysis of upstream intron sequences: Identification of PTB binding motifs as a candidate 
regulatory elements for muscle-specific alternative splicing. Computational analysis of upstream intron 
sequences revealed that over-represented hexamers in the upstream sequence were extremely high in 
uridine content. However, a similar set of U-rich hexamers was also significantly over-represented 
among the dataset of tissue-nonspecific alternative exons (14), suggesting that this feature is 
characteristic of alternatively spliced exons in general, not a specific feature of muscle regulation.  More 
complex words, that were likely to represent binding sites for splicing regulators, were not consistently 
found in these datasets.  
As an alternative approach for identification of upstream regulatory elements, we performed a 
phylogenetic analysis of the distribution of motifs for other known splicing regulatory proteins.  One of 
these is PTB, an inhibitor of splicing for many alternative exons (including muscle-specific exons (36-
38) via binding to pyrimidine rich sequences such as CUCUCU (39), UCUU (40), and related sequences 
(41).  Putative PTB binding sites were previously reported to be significantly over-represented upstream 
of  brain-enriched alternative exons (13). Here, we chose to examine the distribution of both CUCUCU 
and UCUU motifs in the muscle enriched datasets, relative to their frequency in the control datasets of 
constitutive exons, to test for involvement of PTB in regulation of the muscle-enriched exons.  In all 
four species, the muscle-enriched datasets showed strong over-representation of both representative PTB 
binding sites in the proximal upstream intron (Figure 5).  CUCUCU was concentrated mainly in the U200 
region. UCUU was focused even more tightly in the U100 region (Figure 5, bottom), where it was 
consistently among the top five over-represented sequences in all four species. Lesser over-
representation of UCUU motifs over a broad area of downstream intron sequences was also noted, 
perhaps consistent with previous findings that optimal splicing repression by PTB requires binding sites 
both upstream and downstream of the regulated exon (40,42,43).  
We also probed the role of hnRNP A1, a well known splicing inhibitory protein, by examining 
the incidence of the prototypical A1 binding site, UAGGG (44), in flanking intron regions. In contrast to 
the abundance of candidate PTB binding sites, UAGGG was relatively deficient in the proximal intronic 
regions both upstream and downstream of the muscle-enriched exons (Figure 6). All four datasets 
exhibited this “A1-deficient” zone near the regulated exons, although the boundaries of the zone varied a 
bit between species.  Together, these results suggested that suggests that PTB may play a widespread 
role in the negative regulation of muscle-enriched exons in other tissues. While high affinity A1 sites 
may be less abundant, we cannot rule out involvement of lower affinity of A1 binding sites in the 
regulation of muscle-specific splicing.  
Finally, as a control we examined the distribution of YCAY binding sites for the neural splicing 
regulator, NOVA1. This element is not expected to play a role in muscle-specific splicing events, and 
indeed it was much less abundant than the CELF binding motif (results not shown). 
 
Motifs identified via position weight matrix analysis are consistent with word analyses. Because many 
splicing factors bind RNA degenerate oligonucleotide sequences, we performed additional analyses in 
which degeneracy was considered in the motif searches through the use of a position weight matrix 
(PWM) approach. Over-represented PWMs were obtained using the DME algorithm (63) using multiple 
parameter setting in order to avoid bias from DME. Functional PWMs were identified by assessing their 
correlation with muscle expression using linear splines. In contrast to previous approaches (D. Das, Z. 
Nahle & M.Q. Zhang, Mol. Syst. Biol., 2006, in press), we accounted for both strength of PWM and the 
number of putative binding sites in this approach. Degenerate 6nt and 4nt sequences that were over-
represented in the proximal downstream intron sequence are shown in Table II.  Notably, all of the top 
10 over-expressed PWM hexamer motifs in the D200 region are consistent with the major over-
expressed unique motifs identified above. Seven of the motifs, including the six most statistically 
significant sequences, represent close matches to the Fox binding site, UGCAUG; two (NHCUAA and 
HCUAAN) are very similar to the novel ACUAAC; and the remaining sequence (SUKUGS) resembles UG-
rich binding site for CELF proteins. Among the over-expressed 4-mers in the D50 region, the top-
scoring motif (UGCM) incorporates the CELF binding motif UGC.  Finally, in the U200 region, all of the 
statistically over-represented hexamers were quite pyrimidine-rich relative to the control group.  Further 
investigation will be required to determine whether PTB is the major splicing regulator that binds to 
these elements, or whether perhaps additional factor(s) might be involved in regulating muscle exon 
expression from the position of the upstream intron.  
 
Frequent occurrence of muscle-enriched exons in genes encoding proteins with functions in 
cytoskeletal organization.  Previous studies have demonstrated that the brain-specific alternative 
splicing factor, NOVA1, modulates the splicing of many components of the neuronal synapse (11). We 
hypothesized that the muscle alternative splicing program might similarly coordinate the expression of a 
particular class of genes that share a common pathway or cellular process. Using GoMiner (45) to 
examine the gene ontology (GO) terms associated with each parent gene for the muscle-enriched exons, 
we found a strong association with “cytoskeleton organization and biogenesis”, “microtubule 
stabilization”, and “muscle development” (Supplementary Table IV). These correlations were highly 
statistically significant (p= 0.0001-0.0007), suggesting that the muscle alternative splicing program is 
critical for proper expression of the unique cytoskeleton characteristic of vertebrate muscle. 
 
Discussion 
 A central hypothesis of this work is that carefully orchestrated programs of alternative pre-
mRNA splicing are essential mediators of gene expression during normal metazoan development. Such 
programs may regulate defined subsets of alternative exons in highly specific temporal and spatial 
patterns so as to modify the structure and function of many important proteins according to the 
specialized requirements of each differentiated cell type. In this study, a novel genome-wide exon 
microarray strategy was used to discover a set of highly conserved, muscle-regulated alternative exons. 
We propose that this unique constellation of muscle-specific splicing events is orchestrated by an 
alternative splicing program that modulates the expression of many widely expressed genes in a muscle-
specific manner. Many of the splicing switches are predicted to alter the expression of cytoskeletal 
proteins and signaling proteins, functional studies of which may provide fundamental new insights into 
muscle biology. Thus, alternative splicing switches are likely to be essential for remodeling of muscle 
cell function during normal differentiation.  
It is of great interest to understand the regulatory machinery that coordinates the muscle 
alternative splicing program.  Computational analysis of flanking intron sequences was performed as a 
first step toward characterizing the cis-regulatory motifs that constitute a critical element of this 
machinery. In addition to simple word counting, we also employed several additional strategies- 
correlation analysis with muscle expression, phylogenetic analysis of orthologous datasets in other 
vertebrates, and analysis of more complex motifs using position weight matrices. Together these 
approaches provided substantial additional support for the generality of the findings for muscle splicing 
regulation in vertebrates. Most importantly, we identified a specific alternative splicing motif, UGCAUG, 
the known binding site of Fox1 and Fox2 splicing factors, as a candidate cis-regulatory element for 
mediating muscle-specific alternative splicing switches. Almost one-half of all muscle-regulated exons 
contained UGCAUG motif(s) in the proximal intron sequences, and many of the remainders possess such 
motifs in the more distal intron.  This frequency far exceeds the incidence of UGCAUG elements mapping 
near constitutive exons. Further supporting the functional significance of this motif, UGCAUG over-
representation was correlated with the muscle splicing index and was a highly conserved feature in the 
proximal intron sequences of among vertebrates classes including birds, amphibians, and mammals.  
Given the specific (35,46) and high affinity (47) binding of Fox-1 related splicing factors to 
(U)GCAUG, the Fox proteins are ideally designed to play a broad role in specifying a restricted set of 
alternative exons to be spliced at the appropriate stage of muscle differentiation. A similar hypothesis 
was proposed earlier for Fox function in brain-enriched splicing events (12-14) and in smaller sets of 
muscle-enriched exons (13,28). Therefore, we propose that Fox proteins alone do not determine the 
tissue-specificity of such splicing switches, but instead they require additional interacting co-factors to 
accomplish this regulatory feat. Our results further suggest that splicing factors in the CELF family, 
already well known to regulate several muscle-specific splicing events, likely cooperate with Fox 
proteins on a broader scale to regulate the muscle splicing program. In a subset of cases, muscle exons 
may be regulated by binding of as yet unknown proteins to ACUAAC elements in the downstream 
proximal intron (28).  
A hypothetical model for Fox-mediated alternative splicing switches is shown in Figure 6. In 
undifferentiated cells and nonmuscle cells, we propose that Fox activity is relatively low in comparison 
to splicing silencer activity; Fox-regulated exons will thus be predominantly skipped in these cells. 
Likely silencer proteins include members of the PTB family, since a high focal concentration of PTB 
binding sites was identified upstream of muscle-enriched exons among the four vertebrate genomes 
(Figure 4). In contrast, high affinity binding sites for hnRNP A1 (44), another known intronic silencer 
protein, (e.g., (48)), were relatively deficient in the proximal introns (Figure 5); however, it is possible 
that lower affinity sites may antagonize Fox and CELF proteins in some genes. Next, the model 
proposes that differentiation is accompanied by a relative increase in the activity of Fox and/or CELF 
proteins, leading to greatly increased inclusion of the adjacent alternative exons. This model is 
consistent with similar proposals for the regulation of individual neural- and muscle-specific exons (1,3) 
by antagonistic interactions between positive and negative factors, but extends the hypothesis to cover a 
broad range of exons in the muscle alternative splicing program.  
Disruption of normal CELF activity can cause human disease and aberrant splicing of target pre-
mRNAs. For example, myotonic dystrophy is a triplet repeat disease in which in which CUG (or 
alternatively, UGC) repeats alter the splicing program of multiple muscle transcripts (49-56). 
Analogously, targeted disruption of cardiac CELF activity disrupts alternative splicing causes 
cardiomyopathy (18).  The muscle-enriched exons identified in this study may represent additional 
targets of CELF activity, and it seems likely that perturbed alternative splicing of these transcripts may 
contribute to the pathology in these diseases. By analogy, we anticipate that aberrant Fox expression in 
vivo will also cause disease that includes muscle pathology.  
 The exon microarray employed in this study has dramatically enhanced our ability to track the 
expression of individual exons during development and differentiation. This experimental approach 
complements and extends previous computational strategies for identification of conserved alternative 
exons (57,58) by confirming and describing the tissue-specificity for alternative exon expression. The 
high resolution picture of gene expression that is emerging from these studies should have a major 
impact on our understanding of the biology of the genes, by unmasking many previously unappreciated 
isoforms of important cellular proteins (59).  Moreover, by defining exon datasets with shared 
expression patterns, these arrays will facilitate computational analysis of candidate regulatory motifs 
that mediate tissue-specific alternative splicing and give rise to the complex biology. Although the 
current study only considered internal cassette exons, it should be possible to utilize the same approach 
for analysis of tissue-specific alternative first or last exons that must require yet additional regulatory 
mechanisms. With continued improvements in the technologies for detecting tissue-specific exon 
expression and the computational approaches for data analysis, we should gain many critical new 





Identification of muscle-enriched alternative exon and control exon data sets.  The muscle-enriched 
alternative exon dataset from humans was identified using an algorithm called the splicing index. 
Briefly, probeset intensities from individual exons are corrected for transcription rate by dividing the 
median intensity of probesets from well annotated exons (Ensembl / RefSeq) from the same gene.  This 
gene-level-normalized intensity is then compared between groups of samples using a Student T-Test.  
For this analysis, we compared three biological replicates each of heart and skeletal muscle to as a group 
to the three biological replicates of 14 other normal adult human tissues as a second group. 
 After removing non-expressed genes and probesets that are not detected above background, the 
T-Test results were further filtered using a 0.5 minimum fold change and remaining probesets are sorted 
by P-value.  In an attempt to generate a list of high-confidence muscle-enriched internal cassette exons 
the T-Test results were manually filtered by observing the expression data in genomic context.  
Probesets that mapped to alternative transcriptional starts, alternative 3’ ends, alternative poly 
adenylation sites, and alternative 5’ or 3’ splice sites were removed.  Only probesets that showed clear 
muscle-enrichment relative to nearby constitutive exons were kept for further analysis.  Probesets were 
then mapped to the May, 2004 human genome using the BLAT tool from the UCSC Genome Browser 
(60).  Exact exon boundaries were determined by comparison to EST and mRNA sequences requiring 
consensus splice sites.  The majority of targeted probesets mapped to previously annotated cassette 
exons. 
For phylogenetic analysis, the orthologous exons were identified in another mammalian genome 
(mouse; Mus musculus), in an avian genome (chicken; Gallus gallus), and in an amphibian genome 
(frog; Xenopus tropicalis) using VISTA alignment tools. Automatic alignment was successful at finding 
most of the longer alternative exons directly, but in a few cases the alignments were adjusted manually. 
The tissue-nonspecific alternative exon dataset was derived as described previously (14) from the 
European Bioinformatics Institute database of human alternative exons 
(http://www.ebi.ac.uk/asd/altextron/index.html).  
Control exon datasets were generated from randomly selected chromosomal regions by 
extraction from RefSeq annotation databases to get exon coordinates. Control groups for the mammalian 
and chicken genomes were described previously (14).  
The muscle-enriched datasets and the control datasets will be available at 
http://gsd.lbl.gov/splicing/. 
Computational analysis. Candidate regulatory elements were predicted computationally by identifying 
oligonucleotide sequences (words) that were over-represented in each tissue-specific dataset, relative to 
the control datasets, using the algorithm described previously (13). For each word a contrast score was 
calculated as the difference in frequency in the tissue-specific dataset versus the control dataset.  The 
statistical significance of contrast scores was estimated using resampling statistics as described (13) with 
the following modification.  In this paper the probability refers to the chance that any hexamer might 
exhibit a given contrast score in a randomly selected subset of the control sample (equal in size to the 
muscle sample). 
Correlation with expression.  Linear correlation. Counts of hexamers were obtained in the specific pre-
mRNA sequence region (upstream or downstream proximal intron). For each region, a linear model was 
fitted between the logarithm of splicing index ratios and the count of each 6-mer word w across a set of 
exons, { }ewn : 
  ( ) ewwweCe nbaSS ./log +=
Se is the splicing index of exon e and C refers to a reference condition. The splicing ratio was obtained 
as the ratio of the splicing index of the exon to its average across all the tissues. The coefficients aw and 
bw were obtained by maximizing the percent reduction in variance. Percent reduction in variance, Δχ2, is 
defined as (33,34): 
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r  are their respective means. p-values were calculated using an F-test (61): 







where  is the residual sum of squares (RSS) of the final regression model with  terms (1RSS 11 +p 1p  = 
1), and  is the RSS of the model without a specific motif, which has 0RSS 10 +p  terms (  = 0).  is 0p N
the number of exons. This statistic has a  distribution with F 01 pp −  numerator degrees of freedom and 
 denominator degrees of freedom.  11 −− pN
The best fit was obtained for a set of sequences that included the muscle-specific exons 
(foreground set) and a background set of m sequences (m = 300), drawn randomly from a set of 
manually curated 957 cassette exons across the human genome (57). A background set is necessary to 
model the correct dependence of the log ratios on the word count. 25 such random draws were 
performed, and a linear fit was obtained for each such case. The significance of each word reported in 
Table II is the geometric mean of the p-values of all such fits.  
Linear Splines. Regulatory motifs for splicing are often degenerate. To account for this 
degeneracy, we used position weight matrices (PWMs), which are probabilistic representations of 
binding sites for trans-acting factors. PWMs were obtained using the DME algorithm (see below). For 
each PWMμ of width L, each L-mer in the input sequence was assigned a probability score M: 
M = [p1(b1)p2(b2)…pL(bL)]1/L
where  pi(bi) is the probability of observing the base bi at the position i. Thus, the score M always 
assumes a value between 0 and 1. It is related to binding affinity (62).  For each sequence there is a 
continuum of scores arising from a large number of putative binding sites. One needs to determine a cut-
off score to discriminate the true binding sites from the false sites. Such thresholds can be adaptively 
determined using linear splines. PWM scores across exons { }μeM  for a given motif μ were fitted to the 
splicing ratios  using the following model: ({ eCe SS /log )}
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where ( 0,x )θ  is a linear spline: it is x , when , and zero, otherwise. 0≥x μξ , termed knot, corresponds 
to the cut-off score. The coefficients  and  and the location of the knot μa μb μξ  were determined so as 
to maximize Δχ2. It is important to note that Δχ2 depends on the location of μξ . Maximization of Δχ2 
leads to an unbiased and adaptive determination of this threshold for any given PWM. The significance 
of the fit was enumerated using an F-test, as discussed above. Of note, in contrast to previous 
approaches where contribution from only the maximum scoring site was considered, we systematically 
accounted for the contribution from active sites with weaker scores as well. The number of such 
contributing sites is adaptively determined. Thus, both binding affinity and counts of active motifs are 
accounted for in our approach. p-values for each motif was obtained by fitting splines multiple times to a 
combined set of foreground and background sequence sets, similar to the case of linear fits.  
DME  (Discriminating Matrix Enumerator) DME (63,64) is an enumerative search algorithm that finds 
the PWMs over-represented in a foreground set relative to a background set. Muscle specific exons were 
used as the foreground set and a set of 1305 randomly chosen control exons from the human genome as 
background. Both exonic and intronic regions (upstream and downstream) were searched for over-
represented matrices of width 6nts. Default parameter settings were used, except we varied the average 
information content of the PWM from 1.0-2.0 in steps of 0.1. 15 PWMs were obtained for each such 
setting. Correlation analysis was performed on non-redundant sets of matrices. Matrix similarity was 
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Figure 1.  Validation of muscle-enriched patterns of alternative exon expression. RT-PCR 
confirmation of muscle-enriched alternative exon expression. Amplifications were performed usin 
primers in the flanking constitutive exons. Lanes: 1, brain; 2, kidney; 3, liver; 4, stomach; 5, bone 
marrow; 6, testis; 7, heart; 8, skeletal muscle. Arrowheads indicates position of the muscle exon 
inclusion products. 
Figure 2.  Phylogenetic conservation of Fox1 binding sites in the proximal downstream intron. 
Histograms show the over-representation of UGCAUG elements in the proximal intron sequences for 
muscle-enriched exons in four vertebrate species. The highest abundance of UGCAUG elements is 
consistently within the downstream ~200nt (D200) region. Vertical axis, contrast score, i.e. difference in 
motif frequency between muscle datasets and control datasets of constitutive exons, occurrences/nt x 
103; horizontal axis, nt range relative to the alternative exon. 
Figure 3. Phylogenetic conservation of predicted CELF binding sites in the proximal downstream 
intron. Histograms show the relative over-representation of intronic UGUGUG (upper panel) and UGC 
(lower panel) elements in the proximal intron sequences for muscle-enriched exons in four vertebrate 
species. The highest abundance of these candidate CELF binding sites elements is consistently in the 
proximal downstream intron. The axes are the same as in Fig.  1.  
Figure 4.  Phylogenetic conservation of ACUAAC elements in the proximal downstream intron. 
Histograms show the relative over-representation of ACUAAC elements in the proximal intron 
sequences for muscle-enriched exons in four vertebrate species. The highest abundance of ACUAAC 
elements is consistently within the downstream proximal intron. The axes are the same as in Fig. 1. 
Figure 5. Phylogenetic conservation of putative PTB binding sites in the proximal upstream intron 
sequences. Histograms show the relative over-representation of CUCUCU (upper panel) and UCUU 
elements (lower panel) at 100nt intervals upstream and downstream of the muscle-enriched exons, Data 
for human, mouse, chicken, and frog datasets is included. The highest abundance of CUCUCU elements is 
consistently within the upstream U200 region, while UCUU is more focused in the U100 region. The axes 
are the same as in Fig 1. 
Figure 6. Relative deficiency of hnRNP A1 binding sites in the proximal intron sequences in 
phylogenetically conserved. Histograms show the under-representation of UAGGG elements in the 
proximal intron sequences for muscle-enriched exons in four vertebrate species, relative to constitutive 
exons. The lowest frequency of UAGGG elements is consistently found within the proximal intron 
regions upstream and downstream of the regulated exons (boxed). The axes are the same as in Fig. 1. 
Figure 7. Model showing splicing factors implicated in regulation of conserved muscle-enriched 
alternative exons.  Based on the conserved distribution of splicing factor binding sites across multiple 
vertebrate orders and the positive correlation with muscle-specific splicing, CELF and Fox proteins are 
proposed to play major roles in promoting inclusion of muscle-enriched exons. A smaller subset of 
muscle exons may also be enhanced by ACUAAC-binding protein(s) represented in this model as 
protein X. In contrast, the enrichment of candidate PTB binding sites in the proximal upstream intron 
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Figure 3. Phylogenetically conserved enrichment of CELF binding sites (UG repeats and 

















































































Figure 4. Phylogenetically conserved enrichment of ACUAAC candidate splicing 
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Figure 5. Phylogenetically conserved enrichment of candidate PTB splicing factor 
binding sites in the proximal upstream intron. 
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                          Figure 7. Model for regulation of muscle-enriched exons 
 

































UGCAUG* 2.72  (1) 0.29 2.44 2.89x10-15 1.05x10-11 6.79X10-5  
UUUGCA* 1.56  (4) 0.25 1.31 8.14X10-9 1.49X10-5 0.0082 
UUCUGU 1.56  (4) 0.34 1.21 2.22X10-4 1.17X10-2 0.248 
UGUUUG 1.56  (4) 0.40 1.16 1.77X10-4 1.05X10-2 0.190 
UUGUUU 1.46  (8) 0.37 1.09 6.14X10-4 2.24X10-2 0.534 
GUGUGU* 1.65  (3) 0.58 1.07 3.57X10-4 1.57X10-2 0.032  
UUGCAU* 1.17 (21) 0.11 1.06 1.21X10-7 6.29X10-5 0.036  
UGUGUG 1.85  (2) 0.83 1.02 2.95X10-4 1.38X10-2 0.121 
UUUUCU 1.46  (8) 0.48 0.99 3.51X10-3 6.28X10-2 0.221 
AUGCAU* 1.07 (33) 0.10 0.99 2.91X10-8 2.72X10-5 0.011  
UGUGUU 1.36 (10) 0.39 0.97 1.36X10-4 9.06X10-3 0.569 
AUUUUU 1.26 (16) 0.30 0.96 3.56X10-6 1.10X10-3 0.468 
UGUUUU 1.36 (10) 0.41 0.96 3.07X10-4 1.42X10-2 0.146 
GCUUUU 1.17 (21) 0.21 0.96 1.33X10-4 9.02X10-3 0.234 
UCUGUU 1.26 (16) 0.31 0.96 1.97X10-4 1.12X10-2 0.453 
UUCAAA 1.07 (33) 0.13 0.94 4.45X10-8 3.25X10-5 0.219 
UUAAAU 1.07 (33) 0.13 0.94 1.21X10-7 6.29X10-5 0.583 
CUGCUU 1.36 (10) 0.44 0.92 4.54X10-4 1.86X10-2 0.199 
UUCUAA 1.07 (33) 0.15 0.92 4.74X10-6 1.24X10-3 0.154 
UUUGUU 1.26 (16) 0.35 0.92 5.31X10-2 3.10x10-1 0.335 
GCAUGG* 1.36 (10) 0.47 0.89 4.47X10-5 4.08X10-3 0.0006 
UCUGUG* 1.56  (4) 0.66 0.89 2.10X10-4 1.14X10-2   0.015 
AAUUUU 1.07 (33) 0.19 0.88 3.66X10-4 1.57X10-2 0.600 
GCAUGC 1.07 (33) 0.19 0.88 1.41X10-5 2.44X10-3 0.088 
UGCUUU 1.26 (16) 0.39 0.88 7.54X10-4 2.60X10-2 0.402 
GUGCAU* 1.07 (33) 0.20 0.87 6.82X10-5 5.66X10-3  0.0068 
AGCUUU 1.07 (33) 0.21 0.86 1.91X10-5 2.44X10-3 0.161 
AGAAAU 0.97 (52) 0.14 0.84 1.59X10-5 2.44X10-3 0.366 
UUUUUG 1.17 (21) 0.34 0.83 1.40X10-4 9.16X10-3 0.479 
ACUAAC* 0.88 (69) 0.05 0.82 2.98X10-8 2.72X10-5 0.0006 
 
 
* Over-represented motifs with highly significant hypergeometric and correlation p-
values. 
 
Table II.  Over-represented PWM sequences in the D200, D50, and U200 intron regions. 
 

















4 CCGA 0.64 
 
 












1. Nucleotide abbreviations: W = A or T; S = G or C; D = A or G or T; V = A or C or G;  
H = A or C or U; M = A or C; K = G or U; R = A or G; Y = C or U. 
 
2. Shown are the correlation P-values. 
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 Supplementary Table I .  Human muscle-enriched exons and their orthologs in mouse, chicken, and 
frog. 














1 MTMR3 93393158 chr22:28,744,000-28,744,026 145kb + + + 
2 RBAF600 99925658 chr1:19,221,563-19,221,595 135kb + + + 
3 RSN 95562371 chr12:121,360,538-121,360,570 151kb + + no 
4 FAT 98278525 chr4:187,886,671-187,886,706 136kb + + + 
5 INSR 93783876 chr19:7,101,508-7,101,543 177kb + no no 
6 ACAS2 93630018 chr20:32,966,682-32,966,720 51kb + + + 
7 TNNT3 105671755 chr11:1,914,769-1,914,809 19kb + + + 
8 DYSF 99552338 chr2:71,688,135-71,688,176 233kb + + no 
9 TMEM16E 96039431 chr11:22,196,368-22,196,409 87kb + + + 
10 RBM9 103730784 chr22:34,473,160-34,473,202 284kb + + + 
11 MYO9B 103967726 chr19:17,182,142-17,182,189 112kb + + + 
12 WDFY3 98362890 chr4:86,005,193-86,005,243 297kb + + no 
13 PRDM2 100258831 chr1:13,840,919-13,840,974 123kb + + no 
14 ARGBP2 98280215 chr4:186,931,658-186,931,714 369kb + + + 
15 SORBS1   (60nt) 96137820 chr10:97,072,493-97,072,552 250kb + + + 
16 NBEA 95353689 chr13:35,118,006-35,118,068 80kb + + + 
17 TEAD3 97648546 chr6:35,555,815-35,555,877 23kb + + + 
18 SORBS1   (66nt) 96138591 chr10:97,121,731-97,121,796 250kb + + + 
19 MFN2 100261811 chr1:11,976,846-11,976,913 33kb + no no 
20 LRRFIP2 98804302 chr3:37,121,950-37,122,018 123kb + no + 
21 LRRFIP1 99364359 chr2:238,441,843-238,441,914 73kb + + + 
22 SORBS1  (75nt) 96138411 chr10:97,144,748-97,144,822 250kb + + + 
23 Y226 98619346 chr3:198,906,255-198,906,329 66kb + + no 
24 TPM2 105745930 chr9:35,674,729-35,674,804 8kb + + + 
25 TPM1 104276978 chr15:61,143,316-61,143,394 19kb + + + 
26 FXR1 105005302 chr3:182,171,565-182,171,645 64kb + + + 
27 ITGB1 104606546 chr10:33,235,997-33,236,077 58kb + + no 
28 ABLIM1 96108548 chr10:116,235,046-116,235,129 249kb + + no 
29 PPP1R12A 95444717 chr12:78,673,817-78,673,900 161kb + + no 
30 FBXO31 94437555 chr16:85,949,518-85,949,604 54kb + + + 
31 ANK2    (92nt) 98509599 chr4:114,656,850-114,656,941 334kb + no + 
32 ANK2    (93nt) 98509569 chr4:114,651,293-114,651,385 334kb + + + 
33 SVIL 96212858 chr10:29,855,896-29,855,991 278kb + + + 
34 CLASP1 99203420 chr2:121,865,045-121,865,166 312kb + + + 
35 SORBS1  (102nt) 96138601 chr10:97,121,073-97,121,174 250kb + + + 
36 CAPZB 99923983 chr1:19,414,542-19,414,674 147kb + + + 
37 PLD1 98655298 chr3:172,887,177-172,887,290 210kb + + no 
38 BRAF 97125440 chr7:139,938,650-139,938,806 190kb + + + 
39 CTL2 103985997 chr19:10,614,573-10,614,697 19kb + no no 
40 SLC25A3 105519144 chr12:97,491,679-97,491,803 8kb + + + 
41 TPM1 94896256 chr15:61,123,279-61,123,404 19kb + + + 
42 UNR 99800031 chr1:114,996,190-114,996,336 33kb + no + 
43 CACNB1 94197648 chr17:34,595,719-34,595,893 13kb + no no 
44 NEK6 96612790 chr9:124,134,672-124,134,856 93kb no no no 
45 SMTN 93390102 chr22:29,821,425-29,821,589 23kb + + no 
46 TBC1D4 95223108 chr13:74,796,374-74,796,538 197kb + + + 
47 TRIP10 103991857 chr19:6,697,040-6,697,207 12kb + no no 
48 MAST2 100199876 chr1:46,095,021-46,095,235 232kb + + + 
49 LDB3 104624683 chr10:88,436,806-88,437,009 31kb + + + 
50 NACA    95467208 chr12:55,395,922-55,396,257 14kb + no no 
51 UBE4B 10026653 chr1:10,100,521-10,100,907 148kb + + + 
52 PRKWNK1 95711975 chr12:859,000-859,458 155kb + + + 
53 MAPT 94343664 chr17:41,416,381-41,417,133 131kb + no no 
54 SORBS1  (774nt) 96137735 chr10:97,086,268-97,087,041 250kb + + + 
55 NACA    (1734nt) 95467147 chr12:55,399,777-55,401,510 14kb no no no 
56 TACC2 96273853 chr10:123,832,152-123,837,464 270kb + no no 
 
Supplementary Table II. Candidate regulatory motifs for muscle-specific alternative splicing  in the 
proximal downstream intron (D200) of several vertebrate species. 
 
dataset species muscle freq. 






UGCAUG 2.72  (1) 0.29 2.44 0.0004 
UUUGCA 1.56  (4) 0.25 1.31 0.0351 
UUCUGU 1.56  (4) 0.34 1.21 0.0359 
UGUUUG 1.56  (4) 0.40 1.16 0.0362 
UUGUUU 1.46  (8) 0.37 1.09 0.0363 
GUGUGU 1.65  (3) 0.58 1.07 0.0363 
UUGCAU 1.17 (21) 0.11 1.06 0.0363 
UGUGUG 1.85  (2) 0.83 1.02 0.0370 







AUGCAU 1.07 (33) 0.10 0.99 0.0374 
UGCAUG 2.20  (2) 0.65 1.55 0.0122 
ACUAAC 1.34  (9) 0.12 1.21 0.0418 
GCAUGG 1.53  (5) 0.37 1.16 0.0418 
UGUGUG 2.29  (1) 1.28 1.01 0.0579 
UACUAA 1.05 (26) 0.05 1.00 0.0812 
UGCUUG 1.34  (9) 0.37 0.97 0.0812 
CAUUAA 1.05 (26) 0.12 0.93 0.0827 
CUGUGU 1.81  (3) 0.89 0.92 0.0827 







UUAACU 0.95 (43) 0.11 0.85 0.1137 
UGCAUG 2.76  (1) 0.48 2.28 <0.0001 
UGUGUG 2.52  (2) 0.62 1.90 <0.0001 
GUGUGU 2.16  (3) 0.41 1.75 <0.0001 
CUGCAU 2.16  (3) 0.71 1.45 0.0001 
AGUGUG 1.80 (10) 0.38 1.41 0.0001 
GUGUGC 1.80 (10) 0.39 1.41 0.0001 
UUUUGU 2.16  (3) 0.77 1.39 0.0001 
UUUGUG 1.92  (7) 0.62 1.30 0.0003 







AAGUGU 1.56 (15) 0.30 1.26 0.001 
UGCAUG 3.58  (1) 0.49 3.09 <0.0001 
GUGUGU 2.15  (5) 0.44 1.71 0.0001 
ACUAAC 1.72  (9) 0.20 1.51 0.0005 
UGUGUU 2.29  (2) 0.85 1.44 0.0007 
CUGUUU 2.15  (5) 0.75 1.40 0.0017 
UUUGCA 2.29  (2) 0.92 1.37 0.0017 
GCAUGU 1.72  (9) 0.38 1.34 0.0017 
UGUGUG 1.86  (7) 0.61 1.25 0.0048 







UACUAA 1.72  (9) 0.48 1.24 0.0048 
AUUUUU 1.60  (3) 0.30 1.30 <0.0001 
UAUUUU 1.39  (6) 0.20 1.20 <0.0001 
CUUUUU 1.55  (4) 0.37 1.18 <0.0001 
UUUUUU 1.70  (1) 0.53 1.04 <0.0001 
UCUUUU 1.34 (17) 0.31 1.02 <0.0001 
UUUAAU 1.19 (22) 0.17 0.98 0.0001 
AAAGAA 1.13 (11) 0.16 0.95 0.0001 
UUUUUA 1.24 (22) 0.29 0.90 0.0002 








UAAUUU 1.08 (11) 0.19 0.89 0.0001 
 
 
Supplementary Table III. Candidate regulatory motifs in the proximal upstream intron (U200).  
dataset species muscle freq. 






UUUUUU 3.70  (1) 0.38 3.32 <0.0001 
UUCUUU 3.30  (3) 0.47 2.84 <0.0001 
UUUCUU 3.31  (2) 0.5 2.73 <0.0001 
AUUUUU 2.82  (4) 0.35 2.48 <0.0001 
UUUUGU 2.82  (5) 0.41 2.41 <0.0001 
UUUUUC 2.72  (8) 0.40 2.32 <0.0001 
UCUUUU 2.72  (6) 0.43 2.30 <0.0001 
UUUUUG 2.63 (10) 0.36 2.26 <0.0001 







UUUUCU 2.72  (7) 0.66 2.06 <0.0001 
UUUUCU 2.86  (2) 0.88 1.99 <0.0001 
UUUCUU 2.96  (1) 1.02 1.94 <0.0001 
UUUUUU 2.48  (4) 0.56 1.92 <0.0001 
UUCUUU 2.77  (3) 0.98 1.78 <0.0001 
UUUUUC 2.00 (11) 0.42 1.58 <0.0001 
CUCUCU 2.39  (5) 1.00 1.38 0.0001 
CCUCCU 1.91 (16) 0.56 1.35 0.0014 
CUCCUC 1.91 (14) 0.62 1.29 0.0016 







UUUUGU 2.00 (12) 0.77 1.23 0.0035 
UUCUUU 3.72  (1) 1.33 2.39 0.0001 
UUUUUC 3.60  (3) 1.28 2.32 0.0002 
UUUCUU 3.60  (2) 1.34 2.26 0.0002 
UUUUCU 3.36  (4) 1.27 2.09 0.0006 
UUUUUU 3.12  (5) 1.39 1.73 0.0029 
CUUUUU 2.76  (6) 1.06 1.70 0.0033 
CUGUUU 2.52 (10) 0.84 1.68 0.0034 
UUUCCU 2.76  (7) 1.10 1.66 0.0035 







CUCUCU 2.16 (17) 0.56 1.60 0.0061 
UUUUCU 3.87  (1) 1.93 1.93 0.0011 
UUUUUC 3.58  (2) 1.84 1.74 0.0049 
CCCCCC 1.58 (33) 1.28 1.45 0.0248 
UUUCUC 2.15 (12) 0.73 1.42 0.0248 
UUCCCC 1.58 (32) 2.27 1.35 0.0300 
UUCCCU 1.58 (34) 0.35 1.22 0.0539 
UUUCUU 3.01  (4) 1.86 1.15 0.0808 
CUUUUU 3.15  (3) 2.02 1.13 0.0810 







CCUUUU 2.00 (17) 0.90 1.10 0.0834 
UUUUUU 2.99  (1) 0.38 2.61 <0.0001 
AAUUUU 1.70  (7) 0.47 1.54 <0.0001 
UUUUUG 1.86  (4) 0.57 1.49 <0.0001 
CUUUUU 1.86  (5) 0.35 1.44 <0.0001 
UUUCUU 1.91  (3) 0.41 1.33 <0.0001 
UUUUCU 1.96  (2) 0.40 1.30 <0.0001 
UUUUGU 1.70  (6) 0.43 1.29 <0.0001 
AUUUUU 1.49 (11) 0.36 1.15 0.0001 








UCUUUU 1.55  (9) 0.66 1.12 0.0001 
 










p_value  Description 
GO:0007010 6.2 302 7 0.00011 cytoskeleton organization and 
biogenesis 
GO:0007026 75.9 7 2 0.00029 microtubule stabilization 
GO:0006996 5.2 358 7 0.00032 organelle organization and 
biogenesis 
GO:0007028 5.1 366 7 0.00037 cytoplasm organization and 
biogenesis 
GO:0007517 9.9 107 4 0.00066 muscle development 
 
 
